Modulators of crescentic glomerulonephritis

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2271-2278

  Atkins, Robert C ^a   Nikolic Paterson, David J ^a   Song, Qing ^a   Lan, Hui Y ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cytokine; Interleukin 1; Therapy; Tumor necrosis factor a

Indexed keywords

ANCROD; ANTIBODY; BETA1 INTEGRIN; BROXURIDINE; CD11B ANTIGEN; CD28 ANTIGEN; COLONY STIMULATING FACTOR 1; CYCLINE; CYCLOPHOSPHAMIDE; CYTOKINE; FIBRIN; FIBRONECTIN; GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; SELECTIN; STREPTOKINASE; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CLINICAL TRIAL; FIBRIN DEPOSITION; GENE THERAPY; GLOMERULONEPHRITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030377442     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Kerr PG, Lan HY, Atkins RC. Rapidly progressive glomerulonephritis. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney, 6th ed. Boston: Little, Brown; 1996:in press.
2. Morrin PA, Hinglais N, Nabarra B, Kreis H: Rapidly progressive glomerulonephritis. A clinical and pathologic study. Am J Med 1978;65:446-460.
3. Whitworth JA, Morel-Maroger L, Mignon F, Richet G: The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron 1976;16:1-19.
4. Bolton WK: Treatment of crescentic glomerulonephritis. Nephrology 1995;1:257-268.
5. Holzman LB, Wiggins RC: Consequences of glomerular injury. Glomerular crescent formation. Semin Nephrol 1991;11:346-353.
6. Morel-Maroger Striker L, Killen PD, Chi E, Striker GE: The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 1984; 51:181-192.
7. Silva FG, Hoyer JR, Pirani CL: Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors. Lab Invest 1984;51:404-415.
8. Morita T, Suzuki Y, Churg J: Structure and development of the glomerular crescent. Am J Pathol 1973;72:349-368.
9. Atkins RC, Holdsworth SR, Glasgow EF, Matthews FE: The macrophage in human rapidly progressive glomerulonephritis. Lancet 1976;1:830-832.
10. Cattell V, Jamieson SW: The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit. Lab Invest 1978;39:584-590.
11. Hancock WW, Atkins RC: Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies. Am J Nephrol 1984;4:177-181.
12. Magil AB: Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells. Am J Pathol 1985;120:222-229.
13. Boucher A, Droz D, Adafer E, Noel LH: Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 1987;56:526-533.
14. Tipping PG, Thomson NM, Holdsworth SR: A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol 1986; 67:481-491.
15. Holdsworth SR, Tipping PG: Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest 1985;76:1367-1374.
16. Goyal M, Wiggins R: Fibronectin mRNA and protein accumulation, distribution, and breakdown in rabbit anti-glomerular basement membrane disease. J Am Soc Nephrol 1991;1:1334-1342.
17. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechansims, and therapy. Am J Kidney Dis 1988;XI:449-464.
18. Downer G, Phan SH, Wiggins RC: Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest 1988;82:998-1006.
19. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 1986;55:680-687.
20. Lan HY, Nikolic-Paterson DJ, Atkins RC: Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest 1992;67: 743-751.
21. Rovin BH, Rumancik M, Tan L, Dickerson J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:536-542.
22. Schmouder RL, Stricter RM, Kunkel SL: Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993;44:43-49.
23. Bloom RD, Florquin S, Singer GG, Brennan DC, Kelley VR: Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int 1993;43:1000-1009.
24. Lan HY, Mu W, Meinhard A, et al.: Macrophage migration inhibitory factor (MIF) - a previously unrecognised kidney-derived cytokine - which participates in local macrophage accumulation and proliferation in the progression of rat anti-GBM glomerulonephritis [Abstract]. Kidney Int 1996, in press.
25. Nikolic-Paterson DJ, Main IW, Lan HY, Hill PA, Atkins RC: Adhesion molecules in glomerulonephritis. Springer Semin Immunopathol 1994;16:3-22.
26. Nishikawa K, Guo YJ, Miyasaka M, et al.: Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 1993;177: 667-677.
27. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335.
28. Zhao J, Lan HY, Atkins RC, et al.: CD44 expression in rat anti-GBM glomerulonephritis [Abstract]. Kidney Int 1996, in press.
29. Nishikawa K, Andres G, Bhan AK, et al.: Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis. Lab Invest 1993;68:146-153.
30. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;31:964-972.
31. Li HL, Hancock WW, Dowling JP, Atkins RC: Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 1991;39:793-798.
32. Rennke HG, Klein PS, Sandstrom DJ, Mendrick DL: Cell-mediated immune injury in the kidney: Acute nephritis induced in the rat by azobenzenearsonate. Kidney Int 1994;45:1044-1056.
33. Nishikawa K, Linsley PS, Collins AB, Stamenkovic I, McCluskey RT, Andres G: Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol 1994;24: 1249-1254.
34. Carteron NL, Schimenti CL, Wofsy D: Treatment of murine lupus with F(ab′)2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion. J Immunol 1989; 142:1470-1475.
35. Huang XR, Holdsworth SR, Tipping PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 1994;46:69-78.
36. Merritt SE, Killen PD, Phan SH, Wiggins RC: Analysis of alpha 1 (I) procollagen alpha 1 (IV) collagen, and beta-actin mRNA in glomerulus and cortex of rabbits with experimental anti-glomerular basement membrane disease. Evidence for early extraglomerular collagen biosynthesis. Lab Invest 1990;63:762-769.
37. Buyukbabani N, Droz D: Distribution of the extracellular matrix components in human glomerular lesions. J Pathol 1994;172:199-207.
38. Ng Y, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Expression of basic fibroblast growth factor and its receptor in the progression of rat crescentic glomerulonephritis. Nephrology 1995;1:569-575.
39. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
40. Coimbra T, Wiggins R, Noh JW, Merritt S, Phan SH: Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991;138:223-234.
41. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:55-66.
42. Dinarello CA: Interleukin-1. Adv Pharmacol 1994;25: 21-51.
43. Dinarello CA: Interleukin-1 and tumor necrosis factor: Effecior cytokines in autoimmune diseases. Semin Immunol 1992;4:133-145.
44. Matsumoto K, Dowling J, Atkins RC: Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol 1988;8:463-470.
45. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43: 682-692.
46. Yoshioka K, Takemura T, Murakami K, et al.: In situ expression of cytokines in IgA nephritis. Kidney Int 1993;44:825-833.
47. Boswell JM, Yui MA, Endres S, Butt DW, Kelley VE: Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol 1988;141:118-124.
48. Matsumoto K: Production of interleukin-1 by glomerular macrophages in nephrotoxic serum nephritis. Am J Nephrol 1990;10:502-506.
49. Tomosugi NI, Cashman SJ, Hay H, et al.: Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Inmunol 1989;142:3083-3090.
50. Mulligan MS, Johnson KJ, Todd RF 3rd, et al.: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993;91:577-587.
51. Tang WW, Feng L, Vannice JL, Wilson CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 1994;93:273-279.
52. Karkar AM, Tam FWK, Steinkasserer A, et al.: Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int 1995;48:1738-1746.
53. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC: Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 1993;43:479-485.
54. Nikolic-Paterson DJ, Lan HY, Hill PA, Vannice JL, Atkins RC: Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: Inhibition of intercellular adhesion molecule-1 expression. J Am Soc Nephrol 1994;4:1695-1700.
55. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC: Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 1995;47:1303-1309.
56. Boswell JM, Yui MA, Burt DW, Kelley VE: Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988;141:3050-3054.
57. Hruby ZW, Lowry RP: Mechanisms of glomerular injury in experimental immune nephritis I. Tumor necrosis factor is released by renal glomeruli of nephritic: rats. Arch Immunol Ther Exp (Warsz) 1991;39:563-574.
58. Tipping PG, Leong TW, Holdsworth SR: Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 1991;65:272-279.
59. Hruby ZW, Shirota K, Jothy S, Lowry RP: Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. Kidney Int 1991;40:43-51.
60. Lan HY, Song Q, Nikolic-Paterson DJ, et al.: Functional blocking of TNFa in rat crescentic glomerulonephritis and comparison with IL-1 blockade [Abstract]. Kidney Int 1996, in press.
61. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr: Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation. Mol Cell Biol 1993;13:3301-3310.
62. Chen CC, Manning AM: Transcriptional regulation of endothelial cell adhesion molecules: A dominant role for NF-kappa B. Agents Actions Suppl 1995;47:135-141.
63. Kopp EB, Ghosh S: NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
64. Hiscott J, Marois J, Garoufalis J, et al.: Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: Evidence for a positive autoregulatory loop.Mol Cell Biol 1993;13:6231-6240.
65. Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS: Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappa B. J Immunol 1995;155:902-908.
66. Ruf W, Edgington TS: Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8:385-390.
67. Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994;93:114-120.
68. Erlich J, Tipping P, Holdsworth: Inhibition of tissue factor (TF) reduces renal injury and glomerular fibrin deposition in crescentic glomerulonephritis (GN) [abstract]. Kidney Int, in press.
69. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993;91:2850-2856.
70. Line LG: Gene transfer into the kidney: Promise for unravelling disease mechanisms, limitations for human gene therapy. Kidney Int 1996;49:612-619.
71. Celada A, Nathan C: Macrophage activation revisited. Immunol Today 1994;15:100-102.
72. Jerkins MK, Johnson JG: Molecules involved in T-cell costimulation. Curr Opin Immunol 1993;5:361-377.
73. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994; 15:321-331.
74. Chen F, Sun SC, Kuh DC, Gaydos LJ, Demers LM: Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 1995;214:985-992.
75. Kopp EB, Ghosh S: NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
76. Northrop JP, Ho SN, Chen L: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature (Lond) 1994;369:497-502.
77. Rao A: NF-ATp: A transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 1994;15:274-281.
78. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995;270:286-290.
79. Border WA, Noble NA, Yamamoto T: Natural inhibitor of transforming growth factor-beta protects against scarring in experintental kidney disease. Nature (Lond) 1992; 360:361-364.